Search - tctmd.com

Displaying 1 - 20 of 415

Sort: Relevancy | Date

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Conference News ACC 2026

Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI

Michael O'Riordan

March 28, 2026

News Conference News CRT 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

L.A. McKeown

March 09, 2026

Presentation THT 2026

Keeping Patients out of DanGer

Presenter: Jacob Eifer Moeller

March 03, 2026

Presentation THT 2026

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Presenter: Elric Zweck

March 03, 2026

Presentation THT 2026

Guided by the Swan or flying blind? The role of pulmonary artery catheterization in the DanGer Shock trial

Presenter: Anika Klein

March 02, 2026

News Opinion Off Script

Why Interventionalists Must Work Toward Global Cardiovascular Equity

Tesfaye Telila, MD

February 17, 2026

News Daily News

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

Caitlin E. Cox

January 15, 2026

News Daily News

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

Todd Neale

January 12, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

Presentation TCT 2025

Perspective 3: That Could be DanGer-ous: Impella CP is the Way to Go

Presenter: Marwan F. Jumean

October 28, 2025

Presentation TCT 2025

TCT 258: Age and Sex Modify Long-Term Benefit of Microaxial Flow Pump Treatment in Cardiogenic Shock: A DanGer Shock Analysis

Presenter: Anika Klein

October 27, 2025

Presentation TCT 2025

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

Presenter: Jacob Eifer Moeller

October 27, 2025

Presentation TCT 2025

TCT 284: Geographic Disparities in Mechanical Circulatory Support Use Following the DanGer Shock Trial: Insights from the Epic Cosmos Database

Presenter: Karnav Modi

October 27, 2025

Presentation TCT 2025

TCT 277: Characteristics and Clinical Outcomes of DanGer Shock-Like and Non–DanGer Shock-Like Patients in AMICS Treated With Impella Support: Insights from RECOVER III and NCSI Registries

Presenter: Batla Falah

October 27, 2025

Presentation TCT 2025

TCT 279: Clinical Characteristics of Patients Eligible for the DanGer Shock Trial in a Single-Center ACS Cohort

Presenter: Kohei Osakada

October 27, 2025

Presentation TCT 2025

TCT 272: Escalation of Mechanical Circulatory Support in non-comatose Patients with STEMI-related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Presenter: Norman Mangner

October 27, 2025

Presentation TCT 2025

TCT 255: A Novel Cardiogenic Shock Score Based On Danger shock trial

Presenter: Narumi Irie

October 26, 2025

Presentation TCT 2025

TCT 1543: "Arm"ed and (not so) Dangerous: Axillary Artery Impella CP Assisted Left Main PCI

Presenter: Siva Ketha

October 26, 2025

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

Advertisement

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

Keeping Patients out of DanGer

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Guided by the Swan or flying blind? The role of pulmonary artery catheterization in the DanGer Shock trial

Why Interventionalists Must Work Toward Global Cardiovascular Equity

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Perspective 3: That Could be DanGer-ous: Impella CP is the Way to Go

TCT 258: Age and Sex Modify Long-Term Benefit of Microaxial Flow Pump Treatment in Cardiogenic Shock: A DanGer Shock Analysis

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

TCT 284: Geographic Disparities in Mechanical Circulatory Support Use Following the DanGer Shock Trial: Insights from the Epic Cosmos Database

TCT 277: Characteristics and Clinical Outcomes of DanGer Shock-Like and Non–DanGer Shock-Like Patients in AMICS Treated With Impella Support: Insights from RECOVER III and NCSI Registries

TCT 279: Clinical Characteristics of Patients Eligible for the DanGer Shock Trial in a Single-Center ACS Cohort

TCT 272: Escalation of Mechanical Circulatory Support in non-comatose Patients with STEMI-related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

TCT 255: A Novel Cardiogenic Shock Score Based On Danger shock trial

TCT 1543: "Arm"ed and (not so) Dangerous: Axillary Artery Impella CP Assisted Left Main PCI

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content